These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu. James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077 [TBL] [Abstract][Full Text] [Related]
4. Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches. Fritsch P; Grappin L; Guillermin AM; Fottorino R; Ruffin M; Mièle A Radiat Prot Dosimetry; 2007; 127(1-4):120-4. PubMed ID: 17562647 [TBL] [Abstract][Full Text] [Related]
5. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments. Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474 [TBL] [Abstract][Full Text] [Related]
6. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective? Taylor DM; Hodgson SA; Stradling N Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346 [TBL] [Abstract][Full Text] [Related]
7. Improved Modeling of Plutonium-DTPA Decorporation. Dumit S; Avtandilashvili M; Strom DJ; McComish SL; Tabatadze G; Tolmachev SY Radiat Res; 2019 Feb; 191(2):201-210. PubMed ID: 30566387 [TBL] [Abstract][Full Text] [Related]
8. Three plutonium chelation cases at Los Alamos National Laboratory. Bertelli L; Waters TL; Miller G; Gadd MS; Eaton MC; Guilmette RA Health Phys; 2010 Oct; 99(4):532-8. PubMed ID: 20838095 [TBL] [Abstract][Full Text] [Related]
9. Plutonium-DTPA Model Application with USTUR Case 0269. Konzen K; Brey R; Miller S Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066 [TBL] [Abstract][Full Text] [Related]
10. Structure of a single model to describe plutonium and americium decorporation by DTPA treatments. Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Fattal E; Benech H; Deverre JR; Poncy JL Health Phys; 2010 Oct; 99(4):553-9. PubMed ID: 20838098 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA. Sérandour AL; Grémy O; Fréchou M; Renault D; Poncy JL; Fritsch P Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819 [TBL] [Abstract][Full Text] [Related]
12. Decorporation of plutonium by pulmonary administration of Ca-DTPA dry powder: a study in rat after lung contamination with different plutonium forms. Sérandour AL; Tsapis N; Gervelas C; Grillon G; Fréchou M; Deverre JR; Bénech H; Fattal E; Fritsch P; Poncy JL Radiat Prot Dosimetry; 2007; 127(1-4):472-6. PubMed ID: 17562654 [TBL] [Abstract][Full Text] [Related]
13. Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium. Gervelas C; Serandour AL; Geiger S; Grillon G; Fritsch P; Taulelle C; Le Gall B; Benech H; Deverre JR; Fattal E; Tsapis N J Control Release; 2007 Mar; 118(1):78-86. PubMed ID: 17241685 [TBL] [Abstract][Full Text] [Related]
14. Ustur Case 0846: Modeling Americium Biokinetics after Intensive Decorporation Therapy. Breustedt B; Avtandilashvili M; McComish SL; Tolmachev SY Health Phys; 2019 Aug; 117(2):168-178. PubMed ID: 30489383 [TBL] [Abstract][Full Text] [Related]
15. Predicting plutonium decorporation efficacy after intravenous administration of DTPA formulations: Study of pharmacokinetic-pharmacodynamic relationships in rats. Phan G; Le Gall B; Deverre JR; Fattal E; Bénech H Pharm Res; 2006 Sep; 23(9):2030-5. PubMed ID: 16951998 [TBL] [Abstract][Full Text] [Related]
16. Developing a physiologically based approach for modeling plutonium decorporation therapy with DTPA. Kastl M; Giussani A; Blanchardon E; Breustedt B; Fritsch P; Hoeschen C; Lopez MA Int J Radiat Biol; 2014 Nov; 90(11):1062-7. PubMed ID: 24844369 [TBL] [Abstract][Full Text] [Related]
17. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes. Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919 [TBL] [Abstract][Full Text] [Related]
18. The NCRP wound model: development and application. Guilmette RA; Durbin PW; Toohey RE; Bertelli L Radiat Prot Dosimetry; 2007; 127(1-4):103-7. PubMed ID: 17766262 [TBL] [Abstract][Full Text] [Related]
19. A case of wound intake of plutonium isotopes and 241Am in a human: application and improvement of the NCRP wound model. Schadilov AE; Belosokhov MV; Levina ES Health Phys; 2010 Oct; 99(4):560-7. PubMed ID: 20838099 [TBL] [Abstract][Full Text] [Related]
20. Preferential decorporation of americium by pulmonary administration of DTPA dry powder after inhalation of aged PuO(2) containing americium in rats. Grémy O; Tsapis N; Chau Q; Renault D; Abram MC; Van der Meeren A Radiat Res; 2010 Nov; 174(5):637-44. PubMed ID: 20726717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]